An Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SBI-087 Administered to Japanese Subjects With Rheumatoid Arthritis.
Phase of Trial: Phase I
Latest Information Update: 15 Jun 2012
At a glance
- Drugs SBI 087; SBI 087
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 15 Jun 2012 Actual end date (1 May 2012) added as reported by ClinicalTrials.gov.
- 15 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.